A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Lorcaserin Impurity 4 - Request Quote

Picture of Lorcaserin Impurity 4

Lorcaserin Impurity 4

SZ CAT No:SZ-L051005
CAS No
NA
Mol.F.
C11H15BrClN : HBr
Mol.Wt.
276.6 : 80.9
Inv. Status
Synthesis on demand
Rel. CAS No847063-14-3 (free base)
Shipping Condition Room Temperature

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Lorcaserin Impurity 4 is chemically 2-Bromo-N-(4-chlorophenethyl)propan-1-amine hydrobromide. Lorcaserin Impurity 4 is supplied with detailed characterization data compliant with regulatory guideline. Lorcaserin Impurity 4 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Lorcaserin.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

buy high quality Lorcaserin Impurity 4

Purchase Lorcaserin Impurity 4

Lorcaserin Impurity 4 suppliers

Lorcaserin Impurity 4 manufacturers

Lorcaserin Impurity 4 price

Order Lorcaserin Impurity 4

Enquire Lorcaserin Impurity 4

Lorcaserin Impurity 4 cost

Lorcaserin Impurity 4 Supplier

Lorcaserin Impurity 4 Distributor

Lorcaserin Impurity 4 for Method Validation

Lorcaserin Reference Standard

Lorcaserin Impurity 4 for ANDA Filing

Lorcaserin Impurity 4 for Forced Degradation Studies

Lorcaserin Impurity 4 Identification Standards

Lorcaserin Impurity 4 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,